Washington, D.C. (April 6, 2010) — Pharmaceutical Research and Manufacturers of America (PhRMA) President, International, Christopher A. Singer issued the following statement today regarding the announced path toward a negotiated settlement with Brazil in the WTO Brazil-Cotton dispute.
“PhRMA welcomes the positive developments announced today on the path forward to resolving the Brazil cotton dispute.
“We applaud the efforts by the U.S. and Brazilian Governments that will set the stage to achieving a mutually agreeable solution that would avoid the need for retaliation against American goods and intellectual property. We look forward to the successful completion of these discussions which will in the long run benefit both the people of the U.S. and Brazil.”
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.2 billion in 2008.
PhRMA Internet Address: www.phrma.org
For information on stories of hope and survival, visit: http://sharingmiracles.com/
For information on how innovative medicines save lives, visit: www.innovation.org
For information on the Partnership for Prescription Assistance, visit: www.pparx.org
For more information on public health emergencies, visit: www.rxresponse.org